Loading...
Zoetis Inc (ZTS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong financial performance, consistent dividend growth, and lower-than-historical P/E ratio present a compelling opportunity. Despite some neutral analyst ratings and short-term innovation concerns, the long-term growth outlook and hedge fund buying activity support a positive investment decision.
The MACD is positively expanding with a histogram of 0.238, indicating bullish momentum. RSI is neutral at 61.839, and moving averages are converging, suggesting a consolidation phase. The current price of $128.7 is above the pivot level of $126.35, with resistance at $131.526 and support at $121.174. Overall, the technical indicators suggest a stable to slightly bullish trend.

Zoetis has raised its dividend for 12 consecutive years and expects nearly 10% annualized growth over the next 3-5 years. Hedge funds have significantly increased their buying activity by 228.26% over the last quarter. The company's P/E ratio is lower than historical levels, presenting a valuation opportunity.
Analyst sentiment is mixed, with several downgrades to Neutral and reduced price targets citing an 'innovation air pocket' that could last 1-2 years. The broader market is down, with the S&P 500 declining by 0.96%, which could weigh on sentiment.
In Q4 2025, Zoetis reported revenue growth of 3.02% YoY to $2.387 billion, net income growth of 3.79% YoY to $603 million, and EPS growth of 6.98% YoY to $1.38. Gross margin improved to 68.96%, up 1.38% YoY, reflecting solid financial health and operational efficiency.
Analyst sentiment is neutral overall, with recent price target adjustments ranging from $135 to $140. Analysts express concerns about short-term innovation challenges but acknowledge the company's strong portfolio and long-term potential.